Introduction
Chronic lymphatic leukaemia is a disease of the elderly with a long natural history. Treatment is palliative, with chlorambucil the drug of choice (Livingston and Carter, 1970) . The recognized side effects of chlorambucil include nausea, myelosuppression, skin eruptions and pulmonary fibrosis (Stenfert Kroese, 1975) , but their incidence is low. Although high doses of chlorambucil are epileptogenic in animals (Pradhan and Marsan, 1963) only recently have fits been attributed to chlorambucil therapy, and this in childhood (Williams, Makker and Grupe, 1978 (Pradhan and Marsan, 1963) , monkeys (Mirsky, Bloch-Rojas and McNary, 1966) and rats (Pinel and Chorover, 1972) . Similar EEG changes have been recorded in a 17-year-old patient receiving chiorambucil for choriocarcinoma (Pradhan and Marsan, 1963) . Fits have also been reported following overdosage in a child (Wolfson and Olney, 1957) . Recently, fits have been reported in 7 out of 91 children receiving relatively high therapeutic doses of chlorambucil for glomerulonephritis. In 6 of the children the fits were focal, at least initially (Williams et al., 1978) . Only one of the children had suffered previous seizures. The EEG showed focal (4 children) or diffuse (2 children) abnormalities. When the chlorambucil was withdrawn, seizure activity did not recur. Follow-up EEGs were obtained in 5 of the children, and were normal.
In the case reported here, the onset of fits was twice associated with chlorambucil therapy. They were more frequent and occurred sooner at the higher dose. The relationship of fit frequency to dose level may explain why no fits occurred during the previous 2-month courses of 2 mg/day. Although the patient had both angina and intermittent claudication and may well have had cerebro-vascular disease, there was no previous history of epilepsy. After withdrawing chlorambucil it was possible to stop all anti-epileptic therapy without the fits recurring.
It is likely, therefore, that chlorambucil precipitated this patient's fits, since they recurred when the drug was reintroduced. While clearly uncommon, chlorambucil-induced epilepsy should be considered when convulsions occur in a patient receiving the drug. Although the EEG in experimental chlorambucil-induced epilepsy often resembles petit mal, Palestini et al. (1973) obtained evidence of asynchrony in cats. This may explain the frequent occurrence of focal seizures in patients with chlorambucil-induced epilepsy. However, the focal nature of the fits in the patient reported here may be related to cerebrovascular disease.
